Lataa...
Cardiotoxicity of Immune Checkpoint Inhibitors
PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICIs) have improved the survival of several cancers. However, they may cause a wide range of immune-related adverse events (irAEs). While most irAEs are manageable with temporary cessation of ICI and immunosuppression, cardiovascular toxicity can be a...
Tallennettuna:
| Julkaisussa: | Curr Oncol Rep |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer US
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088903/ https://ncbi.nlm.nih.gov/pubmed/33937956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-021-01070-6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|